28 May 2025
// BIOSPACW
https://www.biospace.com/deals/epilepsy-biotech-nabs-up-to-570m-in-deal-with-italys-angelini-plus-140m-fundraising
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/grin-therapeutics-receives-positive-opinion-for-eu-orphan-designation-for-radiprodil-for-treatment-of-grin-related-neurodevelopmental-disorder-302446917.html
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/grin-therapeutics-receives-priority-medicines-prime-designation-from-ema-for-radiprodil-in-the-treatment-of-grin-related-neurodevelopmental-disorder-302416531.html
17 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-orphan-drug-designation-for-radiprodil-for-the-treatment-of-grin-related-neurodevelopmental-disorder-302402623.html
25 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/grin-therapeutics-receives-fda-breakthrough-therapy-designation-for-radiprodil-302384417.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/grin-therapeutics-presents-data-from-honeycomb-trial-of-radiprodil-at-the-american-epilepsy-society-annual-meeting-302324666.html